Fingolimod Lauryl Sulfate Patent Expiration

Fingolimod Lauryl Sulfate is Used for treating relapsing forms of multiple sclerosis in pediatric patients 10 years of age and older. It was first introduced by Cycle Pharmaceuticals Ltd in its drug Tascenso Odt on Dec 23, 2021.


Fingolimod Lauryl Sulfate Patents

Given below is the list of patents protecting Fingolimod Lauryl Sulfate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Tascenso Odt US10555902 Stable fingolimod dosage forms Jan 19, 2036 Cycle
Tascenso Odt US10925829 Stable solid fingolimod dosage forms Jan 19, 2036 Cycle
Tascenso Odt US9925138 Stable solid fingolimod dosage forms Jan 19, 2036 Cycle


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳